The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
FibroGen, Inc(NASDAQ:FGEN) 
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for...
FibroGen Days Payable Outstanding ttm (DPO)
FibroGen Days Receivable Outstanding ttm (DSO)
FibroGen Days Inventory Outstanding ttm (DIO)
FibroGen Op Cashflow Per Share ttm
FibroGen Free Cashflow Per Share ttm
FibroGen Cash Per Share ttm
FibroGen P/S ratio ttm
FibroGen (GAAP) P/E ratio ttm
FibroGen P/B ratio ttm
No extra charts and metrics for this ticker.